CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

CVS Caremark decided to stop offering Zepbound ... together control 80 percent of the prescription market. The others, Cigna’s Express Scripts and UnitedHealth’s Optum Rx, have not taken ...